|
|
|
Who We Are
►
Board and Advisors |
|
|
David Benaron
David Benaron is a founder of multiple biotechnology start-ups, including Spectros,
FirstScan (in oncology),
Xenogen (in Drug Discovery tools, public in 2004 and acquired by Caliper in 2006), and
Insite (in oximetry and glucose monitoring, spun out to Vital Insite for
Blood pressure monitoring with technology acquired by Masimo). |
|
|
Israel Beinglass, former CTO at Applied Materials (Nasdaq: AMAT), joined the Board of Directors at Spectros Corporation in 2007. Before joining Applied Materials, Beinglass worked at Intel Corporation and IMP. While working at Intel he was the co-inventor of the Selective Tungsten Deposition. Dr. Beinglass has a Ph.D degree from the Hebrew University of Jerusalem in materials science and holds 28 US patents. Currently Beinglass is a consultant to multiple semiconductor equipment concerns, and serves on the BOD and advisory boards at several start ups. |
![]() |
|
Richard Levenson, Chairman of the Board at Spectros, is Director of Research at Cambridge Research Instruments, a leading
provider of tools for Molecular Imaging,
joined the Board of Directors at Spectros Corporation in 2006. Levenson
has promoted and expanded the tools available in Molecular Imaging while
at CRI. |
|
|
Dr. John Brock-Utne, is a senior Anesthesiologist at Stanford University Hospital.
He provides medical practice and hospital economics insight and serves as a non-investor,
independent voice on the Board of Directors at Spectros.
|
|
|
Boris Rubinsky
As a Professor of Bioengineering and Mechanical Engineering, Boris Rubinsky has been closely
associated with a number of biomedical companies, including the first cryoablation company in the U.S., Cryomedical Systems
(CMS). He continues this work with ablation devices for the breast and prostate. His Site Map
interest focuses on heat and mass transfer in bioengineering with particular
emphasis on low temperature biology and cryosurgery, and on introducing
imaging systems (such as MRI and Electrical Impedance Tomography) in the
control loop of minimally invasive surgical procedures. |
|
|
Darryl Bornhop has been an early advocate of, and
leader in, the field of contrast agent development and optical imaging. |
|
|
Dr. Bigio is a leader in the field of monitoring tissues with light.
|
|
|
Dr. Boas is a leader in the imaging of tissue using light. |
|
|
Spectros has a broad based and strong medical advisory board, with advisors in Radiology, Surgery, Gastroenterology, Anesthesia, and Intensive Care.
|
|
|
©2008 Spectros Corporation | Contact Us |